Clinical Trials in Boston

Showing 3061-3080 of 8,503 trials

EndeavorOTC™ Prospective Product Registry

NCT06109051

The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-world setting.

ADHD

Akili Interactive Labs, Inc.198 participantsStarted Oct 2023

Boston, Massachusetts, United States

Active Not Recruiting< 1 mile

EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

NCT05991167

The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.

ADHD

Akili Interactive Labs, Inc.150 participantsStarted Jun 2022

Boston, Massachusetts, United States

COMPLETED< 1 mile

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767

The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort. If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).

Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more

University of Southern California220 participantsStarted Jun 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +42 more locations

EndeavorOTC™ Prospective Product Registry

EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Find Trials by Condition in Boston

The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED

A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Phase I/II Study of Avelumab in Pediatric Cancer Participants

Canadian National PDA Treatment Study

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies